XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.22.0.1

REVENUE RECOGNITION AND COLLABORATIVE ARRANGEMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
REVENUE RECOGNITION AND COLLABORATIVE ARRANGEMENTS |
Schedule of net revenue from collaborative arrangements | Net revenue recognized under our GSK Agreements was as follows:
|  | Year Ended December 31, |
(In thousands) |  | 2021 |  |  | 2020 |  |  | 2019 |
Royalties from a related party - RELVAR/BREO |  | $ | 234,066 |  |  | $ | 221,536 |  |  | $ | 189,424 |
Royalties from a related party - ANORO |  |  | 44,935 |  |  |  | 45,992 |  |  |  | 42,625 |
Royalties from a related party - TRELEGY |  |  | 126,688 |  |  |  | 73,089 |  |  |  | 42,790 |
Total royalties from a related party |  |  | 405,689 |  |  |  | 340,617 |  |  |  | 274,839 |
Less: amortization of capitalized fees paid to a related party |  |  | (13,823 | ) |  |  | (13,823 | ) |  |  | (13,823 | )
Royalty revenue |  |  | 391,866 |  |  |  | 326,794 |  |  |  | 261,016 |
Strategic alliance - MABA program |  |  | — |  |  |  | 10,000 |  |  |  | — |
Total net revenue from GSK |  | $ | 391,866 |  |  | $ | 336,794 |  |  | $ | 261,016 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration